Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
BiondVax Pharmaceuticals
BiondVax Pharmaceuticals logo

BVXV - BiondVax Pharmaceuticals Reuters News

$3.98 -0.2  -4.1%

Last Trade - 26/02/21

Sector
Healthcare
RiskRating
Speculative
Size
Micro Cap
Style
Sucker Stock
Market Cap £33.0m
Enterprise Value £41.9m
Revenue £n/a
Position in Universe 5562nd / 6715
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BVXV Dividends
Reuters News
All News Reuters News Company Announcements
BRIEF-Biondvax Announces Closing Of $12.1 Million Follow-On Underwritten Offering
2nd Feb News
BRIEF-Biondvax Announces Pricing Of $12.1 Million Follow-On Underwritten Offering Of American Depositary Shares
29th Jan News
BRIEF-Biondvax Announces Third Quarter 2020 Financial Results & Business Update
28th Jan News
BRIEF-Biondvax Announces Appointment Of Amir Reichman As New CEO
21st Jan News
BRIEF-BiondVax Announces Topline Results From Phase 3 Clinical Trial Of The M-001 Universal Influenza Vaccine Candidate
23rd Oct '20 News
NASDAQ RESUMED AT 02:12 PM
23rd Oct '20 News
BUZZ-BiondVax Pharma: U.S. shares plunge as flu vaccine fails to meet efficacy goals
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:55 AM
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:52 AM
23rd Oct '20 News
NASDAQ RESUMED AT 11:52 AM
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:48 AM
23rd Oct '20 News
NASDAQ RESUMED AT 11:32 AM
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:27 AM
23rd Oct '20 News
NASDAQ RESUMED AT 11:27 AM
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:22 AM
23rd Oct '20 News
NASDAQ RESUMED AT 11:21 AM
23rd Oct '20 News
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:11 AM
23rd Oct '20 News
NASDAQ RESUMED AT 11:11 AM
23rd Oct '20 News
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:12 AM
23rd Oct '20 News
BRIEF-Biondvax Pharmaceuticals Files Prospectus Supplement Related To Offering Of Adss Of Upto $100 Million
2nd Oct '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.